Literature DB >> 16417768

Outcome of portal injuries following bariatric operations.

Sergio Huerta1, Zhaoping Li, Edward H Livingston.   

Abstract

BACKGROUND: Portal vein thrombosis is rare following Roux-en-Y gastric bypass (RYGBP). Its natural history is dependent on the etiology of the thrombosis. Iatrogenic injuries at bariatric operations resulting in portal vein thrombosis are lethal complications typically necessitating a liver transplant, whereas postoperative portal vein thrombosis without an injury to the portal vein has a benign course. There are currently no data on management or prognostic factors of portal vein thrombosis after bariatric operations.
METHODS: 3 patients referred for liver transplantation secondary to portal vein injury following bariatric surgery between 2000 and 2003 are presented.
RESULTS: 2 super-obese (BMI>or=50 kg/m2) and 1 morbidly obese (BMI 44 kg/m2) patients sustained portal vein injuries during bariatric surgery (RYGBP 2, VBG 1) by experienced bariatric surgeons. In each case, the portal injury was identified and repaired. Thrombosis followed reconstruction in all 3 patients. All 3 underwent emergency liver transplantation, but died of sepsis and multi-organ failure following transplantation. Review of the literature found no cases of traumatic portal vein injuries following bariatric operations and 2 cases of postoperative portal vein thrombosis: 1 following LRYGBP (BMI 46) and one after a Lap-Band (BMI 41).
CONCLUSION: Injury to the portal vein resulting from difficulty in discerning the anatomy of the intra-abdominal structures in the morbidly obese, is a lethal complication of bariatric surgery. Super-obese patients submitting to bariatric surgery should lose weight, undergo a two-stage bariatric procedure, or undergo laparoscopic RYGBP to minimize the risk of portal injury. Postoperative portal vein thrombosis has a benign course and can be managed conservatively.

Entities:  

Mesh:

Year:  2006        PMID: 16417768     DOI: 10.1381/096089206775222203

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  6 in total

1.  Prevalence of adverse intraoperative events during obesity surgery and their sequelae.

Authors:  Alexander J Greenstein; Abdus S Wahed; Abidemi Adeniji; Anita P Courcoulas; Greg Dakin; David R Flum; Vincent Harrison; James E Mitchell; Robert O'Rourke; Alfons Pomp; John Pender; Ramesh Ramanathan; Bruce M Wolfe
Journal:  J Am Coll Surg       Date:  2012-05-26       Impact factor: 6.113

2.  Intermittent obstructive jaundice following gastric band placement.

Authors:  Nikolaos Arkadopoulos; Christina Palamarou; Andreas Koureas; Panagiotis Sechopoulos; Athanassios Marinis; Konstantinos Kostopanagiotou; Constantinos Kostopanagiotou; Nikolaos Dafnios; Vassilios Smyrniotis
Journal:  Obes Surg       Date:  2007-02       Impact factor: 4.129

3.  Portomesenteric vein thrombosis after laparoscopic sleeve gastrectomy.

Authors:  José Salinas; Diego Barros; Napoleón Salgado; Germán Viscido; Ricardo Funke; Gustavo Pérez; Fernando Pimentel; Camilo Boza
Journal:  Surg Endosc       Date:  2014-02-26       Impact factor: 4.584

4.  Preoperative weight loss decreases the operative time of gastric bypass at a Veterans Administration hospital.

Authors:  Sergio Huerta; Serag Dredar; Elizabeth Hayden; Ali A Siddiqui; Thomas Anthony; Massimo Asolati; J Esteban Varela; Edward H Livingston
Journal:  Obes Surg       Date:  2008-05       Impact factor: 4.129

Review 5.  Liver transplantation in the treatment of severe iatrogenic liver injuries.

Authors:  Andrea Lauterio; Riccardo De Carlis; Stefano Di Sandro; Fabio Ferla; Vincenzo Buscemi; Luciano De Carlis
Journal:  World J Hepatol       Date:  2017-08-28

6.  Safety and Feasibility of No.12a Lymph Node Dissection by Portal Vein Approach in Radical Laparoscopic Gastrectomy for Gastric Cancer.

Authors:  Hai-Peng Huang; Wen-Jun Xiong; Yao-Hui Peng; Yan-Sheng Zheng; Li-Jie Luo; Jin Li; Zi-Ming Cui; Xiao-Feng Zhu; Jin Wan; Wei Wang
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.